Metraipolis › archive › dc_5c7ef33b74da
Clinical application and drug resistance mechanism of gemcitabine — Europe PMC PMID:41293424
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41293424
- DOI
- 10.3389/fcell.2025.1702720
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T16:32:37.189Z
- SHA-256 of the archived text
dcdb8774c1f2fa94ec0b590c52913e71113b919571199128b8ce53a0e0862ced- Stable URL of this page
https://metraipolis.com/documento/dc_5c7ef33b74da
How to cite
Clinical application and drug resistance mechanism of gemcitabine — Europe PMC PMID:41293424 — Europe PMC (en), https://europepmc.org/article/MED/41293424 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5c7ef33b74da (Metraipolis archive dc_5c7ef33b74da, sha256 dcdb8774c1f2fa94ec0b590c52913e71113b919571199128b8ce53a0e0862ced)
BibTeX
@misc{dc5c7ef33b74da,
title = {Clinical application and drug resistance mechanism of gemcitabine — Europe PMC PMID:41293424},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41293424},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5c7ef33b74da; sha256 dcdb8774c1f2fa94ec0b590c52913e71113b919571199128b8ce53a0e0862ced},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41293424. Agents can read the archived copy with the MCP tool read_document.